Edition:
United Kingdom

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

4.72USD
18 Sep 2018
Change (% chg)

$0.16 (+3.51%)
Prev Close
$4.56
Open
$4.53
Day's High
$4.74
Day's Low
$4.45
Volume
3,496
Avg. Vol
14,841
52-wk High
$5.72
52-wk Low
$0.67

Chart for

About

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $28.92
Shares Outstanding(Mil.): 26.05
Dividend: --
Yield (%): --

Financials

  CERC.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.21 -- --
ROI: -210.84 1.78 14.61
ROE: -265.70 3.29 16.33

BRIEF-Cerecor Q4 Loss Per Share $0.11

* REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

02 Apr 2018

BRIEF-Cerecor Inc Appoints Peter Greenleaf CEO

* CERECOR APPOINTS PETER GREENLEAF AS CHIEF EXECUTIVE OFFICER

28 Mar 2018

Earnings vs. Estimates